Terms: = Colorectal cancer AND SDHB, PGL4, 6390, ENSG00000117118, SDH1, SDHIP, SDH, IP AND Treatment
181 results:
1. Altered expression of cytokines, chemokines, growth factors, and soluble receptors in patients with colorectal cancer, and correlation with treatment outcome.
Stayoussef M; Weili X; Habel A; Barbirou M; Bedoui S; Attia A; Omrani Y; Zouari K; Maghrebi H; Almawi WY; Bouhaouala-Zahar B; Larbi A; Yacoubi-Loueslati B
Cancer Immunol Immunother; 2024 Jul; 73(9):169. PubMed ID: 38954024
[TBL] [Abstract] [Full Text] [Related]
2. Multifunctional Nanoparticle-Loaded Injectable Alginate Hydrogels with Deep Tumor Penetration for Enhanced Chemo-Immunotherapy of cancer.
Yang X; Huang C; Wang H; Yang K; Huang M; Zhang W; Yu Q; Wang H; Zhang L; Zhao Y; Zhu D
ACS Nano; 2024 Jul; 18(28):18604-18621. PubMed ID: 38952130
[TBL] [Abstract] [Full Text] [Related]
3. Intraperitoneal pharmacokinetics of systemic oxaliplatin, 5-fluorouracil and bevacizumab in patients with colorectal peritoneal metastases.
Rietveld PCS; Guchelaar NAD; van Eerden RAG; de Boer NL; de Bruijn P; Sassen SDT; Madsen EVE; Koch BCP; Verhoef C; Burger JWA; Mathijssen RHJ; Koolen SLW
Biomed Pharmacother; 2024 Jul; 176():116820. PubMed ID: 38810398
[TBL] [Abstract] [Full Text] [Related]
4. CXCL1/IGHG1 signaling enhances crosstalk between tumor cells and tumor-associated macrophages to promote MC-LR-induced colorectal cancer progression.
Wang L; Chen W; Jin H; Tan Y; Guo C; Fu W; Wu Z; Cui K; Wang Y; Qiu Z; Zhang G; Liu W; Zhou Z
Environ Pollut; 2024 Jun; 351():124081. PubMed ID: 38697251
[TBL] [Abstract] [Full Text] [Related]
5. Systematic review and meta-analysis of the management of acute uncomplicated diverticulitis: time to change traditional practice.
Mohamedahmed AY; Zaman S; Das N; Kakaniaris G; Vakis S; Eccersley J; Thomas P; Husain N
Int J Colorectal Dis; 2024 Apr; 39(1):47. PubMed ID: 38578433
[TBL] [Abstract] [Full Text] [Related]
6. Social Determinants of Health and the Link to colorectal cancer Outcomes.
Lorentsen MK; Sanoff HK
Curr Treat Options Oncol; 2024 Apr; 25(4):453-464. PubMed ID: 38498252
[TBL] [Abstract] [Full Text] [Related]
7. TMEM160 promotes tumor immune evasion and radiotherapy resistance via PD-L1 binding in colorectal cancer.
Dai X; Wu Z; Ruan R; Chen J; Huang C; Lei W; Yao Y; Li L; Tang X; Xiong J; Feng M; Deng J
Cell Commun Signal; 2024 Mar; 22(1):168. PubMed ID: 38454413
[TBL] [Abstract] [Full Text] [Related]
8. Downregulation of Roundabout guidance receptor 2 suppresses hepatocellular carcinoma progression by interacting with Y-box binding protein 1.
Liu T; Zhai C; Tian B; Li C; Han S; Wang S; Xuan M; Liu D; Zhao Y; Zhao H; Yu W; Wang J
Sci Rep; 2024 Jan; 14(1):2588. PubMed ID: 38297025
[TBL] [Abstract] [Full Text] [Related]
9. The feedback loop of EFTUD2/c-MYC impedes chemotherapeutic efficacy by enhancing EFTUD2 transcription and stabilizing c-MYC protein in colorectal cancer.
Zhu X; Li C; Gao Y; Zhang Q; Wang T; Zhou H; Bu F; Chen J; Mao X; He Y; Wu K; Li N; Luo H
J Exp Clin Cancer Res; 2024 Jan; 43(1):7. PubMed ID: 38163859
[TBL] [Abstract] [Full Text] [Related]
10. MPDZ is associated with immune infiltration and regulates migration and invasion by switching YAP1 phosphorylation in colorectal cancer.
Chen Z; Ba Y; Zhao N; Dang Q; Xu H; Weng S; Zhang Y; Liu S; Zuo A; Han X; Liu Z
Cell Signal; 2024 Feb; 114():110967. PubMed ID: 37949382
[TBL] [Abstract] [Full Text] [Related]
11. Yogurt Prevents Colitis-Associated colorectal cancer in Mice.
Li X; Yan Y; Du X; Zhang H; Li H; Chen W
Mol Nutr Food Res; 2023 Dec; 67(24):e2300444. PubMed ID: 37897323
[TBL] [Abstract] [Full Text] [Related]
12. EDARADD promotes colon cancer progression by suppressing E3 ligase Trim21-mediated ubiquitination and degradation of Snail.
Yang J; Liao Y; Wang B; Cui L; Yu X; Wu F; Zhang Y; Liu R; Yao Y
Cancer Lett; 2023 Nov; 577():216427. PubMed ID: 37838280
[TBL] [Abstract] [Full Text] [Related]
13. Effect of the Cannabinoid Agonist WIN 55,212-2 on Neuropathic and Visceral Pain Induced by a Non-Diarrheagenic Dose of the Antitumoral Drug 5-Fluorouracil in the Rat.
Vera G; López-Gómez L; Girón R; Martín-Fontelles MI; Nurgali K; Abalo R; Uranga JA
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37833878
[TBL] [Abstract] [Full Text] [Related]
14. Hallmarks and novel insights for gastrointestinal stromal tumors: A bibliometric analysis.
Li C; Wang Q; Jiang KW; Ye YJ
Eur J Surg Oncol; 2023 Dec; 49(12):107079. PubMed ID: 37826966
[TBL] [Abstract] [Full Text] [Related]
15. ACVRL1 drives resistance to multitarget tyrosine kinase inhibitors in colorectal cancer by promoting USP15-mediated GPX2 stabilization.
Lu X; Liu R; Liao Y; Cui L; Sun H; Zhang D; Wang B; Fang L; Guan X; Yao Y; Liu C; Zhang Y
BMC Med; 2023 Sep; 21(1):366. PubMed ID: 37743483
[TBL] [Abstract] [Full Text] [Related]
16. Novel methods to define invasive procedures at the end of life were developed to improve quality of end of life care research: a population-based cohort study in colorectal cancer.
Chamberlain C; Tammes P; Jones T; Pullyblank A; Blazeby JM; Thackray KE; McPhail S; McNair AGK
J Clin Epidemiol; 2023 Nov; 163():51-61. PubMed ID: 37659581
[TBL] [Abstract] [Full Text] [Related]
17. TRIM58 functions as a tumor suppressor in colorectal cancer by promoting RECQL4 ubiquitination to inhibit the AKT signaling pathway.
Sun N; Shen J; Shi Y; Liu B; Gao S; Chen Y; Sun J
World J Surg Oncol; 2023 Jul; 21(1):231. PubMed ID: 37516854
[TBL] [Abstract] [Full Text] [Related]
18. A novel RIP1-mediated canonical WNT signaling pathway that promotes colorectal cancer metastasis via β -catenin stabilization-induced EMT.
Kang AR; Kim JL; Kim Y; Kang S; Oh SC; Park JK
Cancer Gene Ther; 2023 Oct; 30(10):1403-1413. PubMed ID: 37500894
[TBL] [Abstract] [Full Text] [Related]
19. Curcumin targets miR-134-5p to suppress the progression of colorectal cancer through regulating the CDCA3/CDK1 pathway.
Liu F; Zhu C; Ma H; Yang Q
Naunyn Schmiedebergs Arch Pharmacol; 2024 Jan; 397(1):109-122. PubMed ID: 37368030
[TBL] [Abstract] [Full Text] [Related]
20. Intraperitoneal paclitaxel combined with FOLFOX/CAPOX plus bevacizumab for colorectal cancer with peritoneal carcinomatosis (the iPac-02 trial): study protocol of a single arm, multicenter, phase 2 study.
Murono K; Yokoyama Y; Nozawa H; Sasaki K; Emoto S; Matsuzaki H; Kashiwabara K; Ishigami H; Gohda Y; Yamaguchi H; Kitayama J; Ishihara S
Int J Colorectal Dis; 2023 Jun; 38(1):173. PubMed ID: 37340243
[TBL] [Abstract] [Full Text] [Related]
[Next]
